Invivyd, Inc.

IVVD

Invivyd, Inc.

IVVD

Insider Sentiment (TTM):

Last Purchase:2025-11-19Last Sale:2026-02-18Shares Purchased (TTM):50,000Shares Sold (TTM):117,223

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:224,976,894Shares Outstanding:309,670,101Institutional Ownership Pct.:72.65%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	160	184	227	85	35	48	69	107	148	189	201	182
Marketable Securities	-	-	-	-	-	-	-	-	-	-	0	83
Accounts Receivable Net Current	11	12	14	10	9	9	11	8	3	-	0	-
Inventory Net	-	-	-	-	-	-	-	27	5	0	-	-
Prepaid Expense And Other Assets Current	11	9	7	15	16	19	20	9	17	20	24	5
Assets Current	182	205	247	110	59	76	101	151	173	210	225	270
Inventory Noncurrent	25	25	25	25	25	25	26	-	-	-	0	-
Property Plant And Equipment Net	2	2	1	1	1	2	2	2	2	2	2	2
Operating Lease Right Of Use Asset	8	9	2	3	3	1	1	2	1	2	2	3
Other Assets Noncurrent	1	1	0	0	0	0	0	7	2	2	0	0
Assets	219	242	277	139	89	104	130	162	177	215	229	275
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	2	14	18	18	9	10	18	7	1	8	9
Accrued Liabilities Current	20	28	19	25	25	40	50	59	27	34	41	16
Deferred Revenue	-	-	-	-	-	-	-	-	2	-	-	-
Operating Lease Liability Current	2	2	1	1	1	1	1	1	1	1	1	2
Other Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	31	32	34	44	44	50	62	79	37	36	50	27
Operating Lease Liability Noncurrent	7	7	1	2	2	-	0	0	0	1	1	1
Liabilities	38	39	35	46	46	50	62	79	37	37	52	28
Other Liabilities Noncurrent	-	-	-	-	-	-	0	0	0	0	1	1
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,221	1,199	1,196	1,037	976	972	970	967	963	954	910	905
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-1,040	-996	-954	-943	-933	-918	-902	-884	-823	-776	-732	-658
Stockholders Equity	181	203	242	93	43	54	68	83	141	178	177	246
Liabilities And Stockholders Equity	219	242	277	139	89	104	130	162	177	215	229	275
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	295	283	282	214	120	120	120	120	119	119	110	110
Shares Outstanding	295	283	282	214	120	120	120	120	119	119	110	110
Allowance For Doubtful Accounts Premiums And Other…	0	0	0	-	-	-	0	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-11.21%	-22.93%	-49.83%	-	-	-	-	-	-	-	-	-
2025	40.48%	4.40%	3.98%	42.68%	45.18%	120.28%	57.79%	74.68%	37.01%	-21.26%	-16.09%	-36.78%
2024	-23.97%	-54.55%	-45.45%	-16.94%	-2.96%	-6.73%	-26.30%	-29.58%	-54.74%	-25.71%	-12.58%	33.83%
2023	-	-	-	-	-	-	10.00%	181.43%	222.14%	-48.20%	-45.95%	-64.41%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.87	6.47	7.24	2.47	1.33	1.53	1.62	1.92	4.71	5.77	4.47	10.08
Quick Ratio	5.52	6.18	7.04	2.13	0.98	1.14	1.29	1.46	4.11	5.21	3.99	9.89
Working Capital	151.08M	173.26M	213.30M	65.27M	14.83M	26.23M	38.71M	72.56M	136.31M	173.54M	174.59M	243.31M
Leverage & Debt
Debt to Equity	0.21	0.19	0.15	0.50	1.08	0.92	0.92	0.95	0.26	0.21	0.29	0.12
Debt Ratio	0.17	0.16	0.13	0.33	0.52	0.48	0.48	0.49	0.21	0.17	0.23	0.10
Efficiency & Turnover
Asset Turnover TTM	0.38	0.32	0.26	0.33	0.35	0.23	0.14	0.05	0.01	0.00	0.00	0.00
Days Sales Outstanding TTM	62.29	66.02	84.80	65.67	45.76	85.17	156.82	257.37	465.60	-	-	-
Receivables Turnover TTM	5.86	5.53	4.30	5.56	7.98	4.29	2.33	1.42	0.78	-	-	-
Per Share Metrics
Diluted EPS TTM	-0.33	-0.25	-0.30	-0.35	-0.92	-1.19	-1.43	-1.88	-1.71	-1.79	-1.81	-1.54
Free Cash Flow Per Share TTM	-0.28	-0.26	-0.34	-0.35	-0.77	-1.18	-1.44	-1.61	-1.56	-1.58	-1.59	-1.49
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	98.66%	98.90%	98.59%	97.23%	97.04%	95.50%	-	-	-	-	-	-
Operating Profit Margin TTM	-192.81%	-146.38%	-103.99%	-124.37%	-245.67%	-402.61%	-696.80%	-2,026.97%	-9,503.00%	-	-	-
Net Profit Margin TTM	-183.90%	-138.90%	-98.25%	-119.63%	-238.33%	-389.00%	-669.42%	-1,946.87%	-9,003.40%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	26.30%	52.27%	110.47%	332.71%	1,941.08%	-	-	-	-	-	-	-
Net Income Growth (1Y)	-2.54%	-45.63%	-69.11%	-73.41%	-45.97%	-30.99%	-14.46%	32.77%	16.34%	17.53%	-17.68%	-46.76%
EPS Growth (1Y)	-63.50%	-78.95%	-78.73%	-81.33%	-46.27%	-33.45%	-20.97%	21.95%	6.68%	10.58%	-18.63%	-47.41%
Valuation Metrics
P/E TTM	-2.60	-5.19	-8.10	-3.13	-0.78	-0.51	-0.31	-0.54	-0.64	-2.48	-2.17	-1.10
P/B TTM	1.54	1.98	1.76	2.01	2.01	1.34	0.78	1.47	0.93	2.88	2.43	0.76
P/S TTM	4.79	7.21	7.96	3.74	1.86	1.98	2.07	10.54	57.99	-	-	-
Market Cap	279.42M	402.57M	425.37M	187.19M	85.81M	72.53M	52.52M	121.89M	131.30M	513.34M	431.53M	186.58M
Enterprise Value	119.34M	218.42M	366.63M	102.22M	50.91M	24.45M	-16.83M	15.02M	-16.58M	323.96M	230.89M	4.76M
Calculated Values
Free Cash Flow TTM	-88.93M	-79.72M	-58.56M	-59.44M	-92.27M	-141.56M	-170.64M	-192.27M	-186.55M	-182.35M	-173.80M	-163.17M
Net Debt	-160.08M	-184.15M	-58.74M	-84.97M	-34.91M	-48.08M	-69.35M	-106.87M	-147.88M	-189.39M	-200.64M	-181.82M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-18Sale

Owner: Green, Julie

Title: Chief Human Resources Officer

Shares: 20,964

Price/Share: $1.58

Value: $33,123.12

Shares Owned: 107,717

Relationship: Officer

Ownership: Direct

2026-02-18Sale

Owner: Lee, Timothy Edward

Title: Chief Commercial Officer

Shares: 20,964

Price/Share: $1.58

Value: $33,123.12

Shares Owned: 117,717

Relationship: Officer

Ownership: Direct

2026-02-18Sale

Owner: Duke, William E.

Title: Chief Financial Officer

Shares: 20,964

Price/Share: $1.58

Value: $33,123.12

Shares Owned: 107,717

Relationship: Officer

Ownership: Direct

2026-02-18Sale

Owner: Allen, Robert D. Iii

Title: Chief Scientific Officer

Shares: 19,392

Price/Share: $1.58

Value: $30,639.36

Shares Owned: 114,487

Relationship: Officer

Ownership: Direct

2026-02-18Sale

Owner: Andersen, Jill

Title: Chief Legal Officer, Secretary

Shares: 34,939

Price/Share: $1.58

Value: $55,203.62

Shares Owned: 181,736

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-18	Green, Julie	Officer	Chief Human Resources Officer	Direct	Sale	20,964	1.58	$33,123.12	107,717	4
2026-02-18	Lee, Timothy Edward	Officer	Chief Commercial Officer	Direct	Sale	20,964	1.58	$33,123.12	117,717	4
2026-02-18	Duke, William E.	Officer	Chief Financial Officer	Direct	Sale	20,964	1.58	$33,123.12	107,717	4
2026-02-18	Allen, Robert D. Iii	Officer	Chief Scientific Officer	Direct	Sale	19,392	1.58	$30,639.36	114,487	4
2026-02-18	Andersen, Jill	Officer	Chief Legal Officer, Secretary	Direct	Sale	34,939	1.58	$55,203.62	181,736	4
2025-11-19	Mclaughlin, Kevin F	Director	-	Direct	Purchase	50,000	2.50	$125,000.00	50,000	4
2025-08-19	Duke, William E.	Officer	Chief Financial Officer	Direct	Sale	29,643	0.57	$16,896.51	49,344	4
2025-08-19	Green, Julie	Officer	Chief Human Resources Officer	Direct	Sale	29,643	0.57	$16,896.51	49,344	4
2025-08-19	Lee, Timothy Edward	Officer	Chief Commercial Officer	Direct	Sale	29,643	0.57	$16,896.51	59,344	4
2025-08-19	Allen, Robert D. Iii	Officer	Chief Scientific Officer	Direct	Sale	27,420	0.57	$15,629.40	53,068	4
2025-08-19	Andersen, Jill	Officer	Chief Legal Officer, Secretary	Direct	Sale	49,402	0.57	$28,159.14	84,446	4
2024-12-31	Mcguire, Terrance	Director	-	Indirect	Sale	103,474	0.45	$46,563.30	3,066,757	4
2024-12-26	Mcguire, Terrance	Director	-	Indirect	Sale	83,817	0.54	$45,261.18	3,340,520	4
2024-12-19	Mcguire, Terrance	Director	-	Indirect	Sale	152,067	0.43	$65,388.81	3,688,079	4
2024-12-16	Mcguire, Terrance	Director	-	Indirect	Sale	65,359	0.47	$30,718.73	4,012,320	4
2024-12-11	Mcguire, Terrance	Director	-	Indirect	Sale	160,400	0.59	$94,636.00	4,202,679	4
2024-05-29	Mcguire, Terrance	Director	-	Indirect	Sale	112,381	1.66	$186,552.46	4,688,079	4
2024-01-19	Adimab,, Llc	TenPercentOwner	-	Direct	Sale	5,000,000	3.95	$19,750,000.00	21,687,906	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

72.65%

Inst. Shares: 224,976,894

Shares Outstanding: 309,670,101

2025-12-31

139.11%

Inst. Shares: 239,556,987

Shares Outstanding: 172,212,902

2025-09-30

86.94%

Inst. Shares: 147,946,688

Shares Outstanding: 170,169,865

2025-06-30

49.93%

Inst. Shares: 59,919,659

Shares Outstanding: 120,016,132

2025-03-31

57.83%

Inst. Shares: 69,333,169

Shares Outstanding: 119,883,479

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	224,976,894	309,670,101	72.65%
2025-12-31	239,556,987	172,212,902	139.11%
2025-09-30	147,946,688	170,169,865	86.94%
2025-06-30	59,919,659	120,016,132	49.93%
2025-03-31	69,333,169	119,883,479	57.83%
2024-12-31	74,993,728	118,555,073	63.26%
2024-09-30	70,063,084	119,495,284	58.63%
2024-06-30	74,499,496	119,362,670	62.41%
2024-03-31	71,670,351	115,618,209	61.99%
2023-12-31	55,652,351	109,526,053	50.81%
2023-09-30	53,428,693	109,754,812	48.68%
2023-06-30	55,836,586	109,450,071	51.02%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Invivyd, Inc. (IVVD) — SEC Financial Statements & Analysis

Invivyd, Inc. (IVVD) is a biological products, (no diagnostic substances) company, incorporated in DE. Invivyd, Inc. trades on Nasdaq as: IVVD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Invivyd, Inc. reported a 26.30% year-over-year revenue growth, a Gross Profit Margin of 98.66% (TTM), a Debt-to-Equity ratio of 0.21x, a Price-to-Sales (P/S) ratio of 4.79x (TTM), a Price-to-Book (P/B) ratio of 1.54x (TTM), at a market cap of $279.42M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 26.30%
Gross Profit Margin TTM: 98.66%
Debt To Equity: 0.21x
P/S TTM: 4.79x
P/B TTM: 1.54x
Market Cap: $279.42M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Invivyd, Inc. in?

Invivyd, Inc. (IVVD) operates in the Biological Products, (No Diagnostic Substances) industry.

What is IVVD's market cap?

Invivyd, Inc. (IVVD) has a market capitalization of $279.42M as of 2026-06-30.

What exchange does IVVD trade on?

Invivyd, Inc. (IVVD) trades on the Nasdaq.

Where is Invivyd, Inc. incorporated?

Invivyd, Inc. is incorporated in DE.

Invivyd, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Invivyd, Inc. (IVVD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

Invivyd, Inc. (IVVD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.